title: Effects of vitamin E on chronic and acute endothelial dysfunction in smokers.
abstract: OBJECTIVE
  The aims of this study were to determine whether chronic or acute impairment of flow mediated vasodilation (FMD) in the brachial artery of smokers can be restored or preserved by the antioxidant vitamin E.
  
  
  BACKGROUND
  Transient impairment of endothelial function after heavy cigarette smoking and chronic endothelial dysfunction in smokers result at least in part from increased oxidative stress.
  
  
  METHODS
  We studied 22 healthy male smokers (mean +/- SD, 23 +/- 9 cigarettes per day) randomly assigned to receive either 600 IU vitamin E per day (n = 11, age 28 +/- 6 years) or placebo (n = 11, age 27 +/- 6 years) for four weeks and 11 age-matched healthy male nonsmokers. Flow mediated vasodilation and endothelium-independent, nitroglycerin-induced dilation were assessed in the brachial artery using high resolution ultrasound (7.5 MHz) at baseline and after therapy. Subjects stopped smoking 2 h before the ultrasound examinations. At the end of the treatment period, a third scan was obtained 20 min after smoking a cigarette (0.6 mg nicotine, 7 mg tar) to estimate transient impairment of FMD.
  
  
  RESULTS
  Flow mediated vasodilation at baseline was abnormal in the vitamin E (5.3 +/- 3.8, p < 0.01) and in the placebo group (6.4 +/- 3.5, p < 0.05) compared with nonsmoking controls (11.6 +/- 4.7). Using a two-way repeated measures analysis of variance (ANOVA) to examine the effects of vitamin E on FMD, we found no effect for the grouping factor (p = 0.5834) in the ANOVA over time but a highly significant difference with respect to time (p = 0.0065). The interaction of the time factor and the grouping factor also proved to be significant (p = 0.0318). Flow mediated vasodilation values remained similar after treatment for four weeks in both groups but declined faster after smoking a cigarette in subjects taking placebo compared with those receiving vitamin E (p values from successive differences for the time/group factor: 0.0001/0.0017). The transient attenuation of FMD (calculated as the percent change in FMD) was related to the improvement of the antioxidant status, estimated as percent changes in thiobarbituric acid-reactive substances (r = -0.67, p = 0.0024). Nitroglycerin-induced dilation did not differ between study groups at baseline or after therapy.
  
  
  CONCLUSIONS
  These results demonstrate that oral supplementation of vitamin E can attenuate transient impairment of endothelial function after heavy smoking due to an improvement of the oxidative status but cannot restore chronic endothelial dysfunction within four weeks in healthy male smokers.
authors.affiliation: Department of Cardiology, University of Vienna, Austria. TNEUNTEUFL@pop3.kard.akh-wien.ac.at
authors.forename: T
authors.initials: T
authors.lastname: Neunteufl
authors.forename: U
authors.initials: U
authors.lastname: Priglinger
authors.forename: S
authors.initials: S
authors.lastname: Heher
authors.forename: M
authors.initials: M
authors.lastname: Zehetgruber
authors.forename: G
authors.initials: G
authors.lastname: Söregi
authors.forename: S
authors.initials: S
authors.lastname: Lehr
authors.forename: K
authors.initials: K
authors.lastname: Huber
authors.forename: G
authors.initials: G
authors.lastname: Maurer
authors.forename: F
authors.initials: F
authors.lastname: Weidinger
authors.forename: K
authors.initials: K
authors.lastname: Kostner
mesh_terms: D000328:Adult; D001161:Arteriosclerosis / Q000209:etiology / Q000517:prevention & control; D015415:Biomarkers / Q000097:blood; D001783:Blood Flow Velocity / Q000187:drug effects; D001916:Brachial Artery / Q000000981:diagnostic imaging / Q000187:drug effects / Q000503:physiopathology; D008078:Cholesterol, LDL / Q000097:blood; D004311:Double-Blind Method; D004730:Endothelium, Vascular / Q000187:drug effects / Q000503:physiopathology*; D006801:Humans; D008297:Male; D008315:Malondialdehyde / Q000097:blood; D005996:Nitroglycerin; D018384:Oxidative Stress / Q000187:drug effects; D012907:Smoking / Q000009:adverse effects / Q000097:blood / Q000503:physiopathology*; D017392:Thiobarbituric Acid Reactive Substances / Q000378:metabolism; D014463:Ultrasonography; D014664:Vasodilation / Q000187:drug effects*; D014665:Vasodilator Agents; D014810:Vitamin E / Q000097:blood / Q000627:therapeutic use*
chemical_list: D015415:Biomarkers; D008078:Cholesterol, LDL; D017392:Thiobarbituric Acid Reactive Substances; D014665:Vasodilator Agents; D014810:Vitamin E; D008315:Malondialdehyde; D005996:Nitroglycerin